Saturday, September 5, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 23, 2026

1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks

View original at finance.yahoo.com
1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks There's no doubt that artificial intelligence (AI) stocks have been the talk of the stock market for the past few years…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • VGT is not ideal for AI exposure because it excludes major AI companies in other sectors

    60% confidence

  • Now is not the time to jump ship on AI stocks despite slow start to 2026

    60% confidence

  • AWS is the largest cloud platform in the world and thousands of businesses rely on it for daily operations

    60% confidence

  • Artificial intelligence stocks have been the talk of the stock market for the past few years

    60% confidence

  • Training and running AI models require lots of computing power, data storage, and networking, mostly supplied by major cloud platforms

    60% confidence

Data points we hold from this source

Apple Podcasts · etf weight14.33 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks — Source | Via News | Via News